Healthcare Sector Stocks
The Healthcare sector has a total of 1054 stocks, with a combined market cap of $9.6 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 50.98.
Market Cap
9.6T
Revenue
4.67T
Profits
188.33B
PE Ratio
50.98
Profit Margin
4.03%
Dividend Yield
0.38%
1053 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.14T | -2.54% | 2,277,311 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 635.76B | -1.42% | 5,309,356 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 504.76B | 0.16% | 4,631,748 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 375.28B | -1.62% | 3,889,565 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 358.41B | -1.34% | 8,381,069 | 66.57B |
| 6 | NVS | Novartis AG | 294.91B | -3.30% | 4,358,807 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 266.06B | -0.63% | 3,691,378 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 249.14B | -0.40% | 2,039,972 | 47.35B |
| 9 | AMGN | Amgen Inc. | 237.48B | -1.79% | 1,677,451 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 193.48B | -0.73% | 6,070,877 | 30.46B |
| 11 | ABT | Abbott Laboratories | 179.44B | 1.16% | 10,296,890 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 172.38B | -0.96% | 9,188,227 | 50.34B |
| 13 | PFE | Pfizer Inc. | 171.16B | -1.28% | 29,484,131 | 63.70B |
| 14 | DHR | Danaher Corporation | 162.16B | 0.33% | 3,935,928 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 156.78B | 1.90% | 3,004,353 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 132.80B | -2.10% | 832,490 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 125.59B | -2.41% | 9,763,066 | 49.19B |
| 18 | CVS | CVS Health Corporation | 119.55B | -1.07% | 4,601,840 | 412.65B |
| 19 | SYK | Stryker Corporation | 117.81B | 0.02% | 1,984,887 | 25.84B |
| 20 | MDT | Medtronic plc | 116.79B | -1.22% | 6,009,063 | 37.54B |
| 21 | MCK | McKesson Corporation | 116.68B | -1.14% | 628,974 | 410.98B |
| 22 | HCA | HCA Healthcare, Inc. | 101.55B | 0.37% | 1,026,936 | 78.01B |
| 23 | GSK | GSK plc | 101.52B | -0.90% | 3,178,909 | 44.05B |
| 24 | SNY | Sanofi | 99.44B | -0.86% | 2,011,454 | 55.89B |
| 25 | ELV | Elevance Health, Inc. | 95.05B | -1.20% | 1,173,820 | 201.83B |
| 26 | CI | The Cigna Group | 81.11B | -2.83% | 1,780,474 | 282.38B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 80.39B | -1.72% | 527,724 | 15.53B |
| 28 | MRNA | Moderna, Inc. | 79.89B | -1.25% | 21,574,879 | 2.23B |
| 29 | BSX | Boston Scientific Corporation | 66.22B | -0.70% | 8,788,518 | 21.00B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 65.06B | -0.59% | 2,099,206 | 28.42B |
| 31 | COR | Cencora, Inc. | 63.16B | -2.21% | 1,168,295 | 332.77B |
| 32 | NTRA | Natera, Inc. | 58.23B | 0.64% | 1,102,133 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 57.79B | -2.37% | 1,665,839 | 254.25B |
| 34 | ARGX | argenx SE | 54.78B | -0.23% | 295,353 | 5.92B |
| 35 | BDX | Becton, Dickinson and Company | 54.18B | -0.75% | 1,304,246 | 22.48B |
| 36 | VEEV | Veeva Systems Inc. | 52.30B | 0.15% | 1,371,290 | 3.46B |
| 37 | EW | Edwards Lifesciences Corporation | 51.34B | -1.13% | 3,101,599 | 6.51B |
| 38 | HUM | Humana Inc. | 50.68B | 0.26% | 1,201,420 | 145.68B |
| 39 | A | Agilent Technologies, Inc. | 48.79B | -0.47% | 1,760,830 | 7.37B |
| 40 | IQV | IQVIA Holdings Inc. | 45.98B | 0.37% | 981,217 | 16.98B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 45.92B | -1.99% | 5,598,869 | 17.32B |
| 42 | HLN | Haleon plc | 44.92B | -0.96% | 15,066,423 | 14.80B |
| 43 | MDLN | Medline Inc. | 44.82B | -2.26% | 7,439,488 | 29.94B |
| 44 | WAT | Waters Corporation | 44.57B | -0.42% | 907,601 | 4.64B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 44.15B | -1.13% | 397,926 | 4.55B |
| 46 | ONC | BeOne Medicines AG | 42.94B | -1.21% | 315,805 | 6.13B |
| 47 | ILMN | Illumina, Inc. | 40.68B | 0.01% | 1,262,698 | 4.49B |
| 48 | RVMD | Revolution Medicines, Inc. | 40.08B | -0.37% | 1,720,154 | - |
| 49 | BIIB | Biogen Inc. | 37.04B | -1.24% | 1,130,953 | 10.03B |
| 50 | RPRX | Royalty Pharma plc | 36.72B | 0.17% | 4,015,525 | 2.54B |
| 51 | RMD | ResMed Inc. | 35.56B | -0.08% | 1,032,415 | 5.65B |
| 52 | CNC | Centene Corporation | 34.66B | -1.50% | 4,314,169 | 180.30B |
| 53 | ALC | Alcon Inc. | 33.95B | -0.65% | 2,592,439 | 10.86B |
| 54 | ZTS | Zoetis Inc. | 33.48B | -1.18% | 2,860,128 | 9.53B |
| 55 | MTD | Mettler-Toledo International Inc. | 33.47B | -0.85% | 199,334 | 4.13B |
| 56 | GEHC | GE HealthCare Technologies Inc. | 32.27B | 0.10% | 2,975,975 | 21.27B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.98B | -1.43% | 1,032,632 | 4.80B |
| 58 | DXCM | DexCom, Inc. | 29.41B | -0.49% | 5,218,222 | 4.97B |
| 59 | WST | West Pharmaceutical Services, Inc. | 27.60B | -0.48% | 718,052 | 3.33B |
| 60 | DGX | Quest Diagnostics Incorporated | 26.70B | -0.57% | 933,382 | 11.84B |
| 61 | LH | Labcorp Holdings Inc. | 26.68B | -0.30% | 663,981 | 14.35B |
| 62 | ROIV | Roivant Sciences Ltd. | 26.36B | -2.56% | 8,225,577 | 7.53M |
| 63 | PHG | Koninklijke Philips N.V. | 26.36B | -0.11% | 1,342,694 | 20.18B |
| 64 | UTHR | United Therapeutics Corporation | 25.20B | 0.46% | 637,856 | 3.15B |
| 65 | GMAB | Genmab A/S | 23.67B | 9.47% | 13,000,820 | 4.13B |
| 66 | INCY | Incyte Corporation | 23.45B | -1.04% | 1,476,818 | 5.82B |
| 67 | GH | Guardant Health, Inc. | 22.69B | 3.77% | 1,661,448 | 1.18B |
| 68 | STE | STERIS plc | 22.63B | -0.03% | 564,655 | 6.04B |
| 69 | BNTX | BioNTech SE | 22.13B | -1.73% | 828,672 | 3.03B |
| 70 | THC | Tenet Healthcare Corporation | 21.62B | -0.81% | 460,004 | 21.81B |
| 71 | VTRS | Viatris Inc. | 20.67B | -2.60% | 7,217,699 | 14.74B |
| 72 | INSM | Insmed Incorporated | 20.39B | -1.76% | 3,414,135 | 1.14B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.80B | -0.25% | 2,016,774 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 18.72B | 2.33% | 309,307 | 2.84B |
| 75 | RVTY | Revvity, Inc. | 17.72B | 0.94% | 1,113,364 | 2.91B |
| 76 | CRL | Charles River Laboratories International, Inc. | 16.49B | 1.68% | 822,296 | 4.00B |
| 77 | EXEL | Exelixis, Inc. | 15.99B | -1.19% | 2,066,141 | 2.44B |
| 78 | ASND | Ascendis Pharma A/S | 15.98B | 0.16% | 570,275 | 1.20B |
| 79 | SOLV | Solventum Corporation | 14.54B | -2.33% | 1,655,465 | 8.31B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 14.51B | -0.41% | 1,033,338 | 3.37B |
| 81 | ICLR | ICON Public Limited Company | 14.29B | -0.09% | 1,022,544 | 8.29B |
| 82 | HALO | Halozyme Therapeutics, Inc. | 14.26B | 0.88% | 1,530,329 | 1.66B |
| 83 | JAZZ | Jazz Pharmaceuticals plc | 13.89B | -0.30% | 534,999 | 4.60B |
| 84 | BBIO | BridgeBio Pharma, Inc. | 13.40B | 0.65% | 2,373,647 | 713.07M |
| 85 | BAX | Baxter International Inc. | 13.08B | -1.36% | 4,936,026 | 11.47B |
| 86 | SNN | Smith & Nephew plc | 12.91B | -0.16% | 1,337,198 | 6.30B |
| 87 | PEN | Penumbra, Inc. | 12.78B | -0.18% | 360,022 | 1.50B |
| 88 | BTSG | BrightSpring Health Services, Inc. | 12.52B | -1.23% | 1,781,910 | 14.37B |
| 89 | SMMT | Summit Therapeutics Inc. | 12.37B | -0.51% | 3,210,611 | - |
| 90 | EHC | Encompass Health Corporation | 12.24B | -1.52% | 805,860 | 6.21B |
| 91 | TEM | Tempus AI, Inc. | 12.20B | 5.96% | 4,691,093 | 1.43B |
| 92 | FMS | Fresenius Medical Care AG | 12.01B | 2.02% | 733,456 | 22.19B |
| 93 | DVA | DaVita Inc. | 11.71B | -1.32% | 618,097 | 14.01B |
| 94 | AVTR | Avantor, Inc. | 11.69B | 0.82% | 7,873,177 | 6.56B |
| 95 | COO | The Cooper Companies, Inc. | 11.64B | -0.71% | 1,816,892 | 4.24B |
| 96 | TECH | Bio-Techne Corporation | 11.38B | -0.10% | 1,898,363 | 1.22B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.25B | -0.75% | 4,277,981 | 5.02B |
| 98 | UHS | Universal Health Services, Inc. | 11.01B | -0.66% | 450,800 | 18.11B |
| 99 | ALGN | Align Technology, Inc. | 10.98B | -0.64% | 897,339 | 4.14B |
| 100 | GMED | Globus Medical, Inc. | 10.93B | -0.31% | 768,462 | 3.14B |
| 101 | MOH | Molina Healthcare, Inc. | 10.89B | -3.46% | 1,265,898 | 42.08B |
| 102 | BMRN | BioMarin Pharmaceutical Inc. | 10.83B | -1.20% | 1,640,627 | 3.41B |
| 103 | RDY | Dr. Reddy's Laboratories Limited | 10.74B | -0.15% | 3,909,244 | 3.44B |
| 104 | GKOS | Glaukos Corporation | 10.55B | 1.24% | 961,234 | 612.84M |
| 105 | QGEN | Qiagen N.V. | 10.42B | 0.34% | 7,144,401 | 2.10B |
| 106 | PODD | Insulet Corporation | 10.33B | 0.60% | 803,107 | 3.05B |
| 107 | ENSG | The Ensign Group, Inc. | 10.15B | -1.55% | 248,732 | 5.49B |
| 108 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.03B | -4.21% | 234,833 | 1.28B |
| 109 | RGEN | Repligen Corporation | 9.99B | -1.00% | 1,066,105 | 785.10M |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 9.89B | 1.77% | 167,407 | 2.59B |
| 111 | OSCR | Oscar Health, Inc. | 9.56B | -6.99% | 5,174,246 | 15.32B |
| 112 | PCVX | Vaxcyte, Inc. | 9.51B | -3.85% | 2,062,633 | - |
| 113 | HSIC | Henry Schein, Inc. | 9.47B | -1.21% | 836,763 | 13.60B |
| 114 | TXG | 10x Genomics, Inc. | 9.32B | 2.58% | 2,227,582 | 616.91M |
| 115 | CORT | Corcept Therapeutics Incorporated | 9.28B | -20.13% | 3,098,603 | 830.81M |
| 116 | KRYS | Krystal Biotech, Inc. | 9.22B | -2.70% | 270,034 | 440.48M |
| 117 | KYMR | Kymera Therapeutics, Inc. | 9.21B | -0.08% | 516,853 | 105.00M |
| 118 | CAI | Caris Life Sciences, Inc. | 9.04B | 0.91% | 2,264,823 | 989.61M |
| 119 | HNGE | Hinge Health, Inc. | 9.00B | 1.45% | 1,562,167 | 720.06M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 8.96B | -0.79% | 409,154 | 281.99M |
| 121 | BRKR | Bruker Corporation | 8.77B | 0.49% | 1,191,139 | 3.50B |
| 122 | TWST | Twist Bioscience Corporation | 8.77B | 3.28% | 1,858,044 | 431.80M |
| 123 | IBRX | ImmunityBio, Inc. | 8.71B | -1.08% | 5,943,775 | 165.79M |
| 124 | HQY | HealthEquity, Inc. | 8.60B | 2.97% | 1,020,374 | 1.36B |
| 125 | CYTK | Cytokinetics, Incorporated | 8.51B | -1.76% | 985,820 | 67.67M |
| 126 | SYRE | Spyre Therapeutics, Inc. | 8.44B | -2.17% | 502,891 | - |
| 127 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.20B | -0.58% | 860,189 | 669.50M |
| 128 | ATR | AptarGroup, Inc. | 8.05B | -1.21% | 354,358 | 3.93B |
| 129 | TGTX | TG Therapeutics, Inc. | 7.68B | 1.90% | 1,978,229 | 799.54M |
| 130 | ABVX | ABIVAX Société Anonyme | 7.68B | -2.46% | 425,657 | 5.33M |
| 131 | AXSM | Axsome Therapeutics, Inc. | 7.60B | -7.07% | 1,578,672 | 776.57M |
| 132 | PACS | PACS Group, Inc. | 7.54B | 0.29% | 1,459,184 | 5.55B |
| 133 | ALKS | Alkermes plc | 7.32B | -1.24% | 872,895 | 1.67B |
| 134 | IONS | Ionis Pharmaceuticals, Inc. | 7.13B | -2.23% | 3,015,008 | 874.09M |
| 135 | AMRX | Amneal Pharmaceuticals, Inc. | 7.10B | -0.49% | 4,898,445 | 3.12B |
| 136 | PRAX | Praxis Precision Medicines, Inc. | 7.06B | -2.30% | 371,647 | 7.46M |
| 137 | GRFS | Grifols, S.A. | 6.79B | 1.48% | 992,340 | 8.48B |
| 138 | CHE | Chemed Corporation | 6.68B | -1.38% | 156,991 | 2.60B |
| 139 | LNTH | Lantheus Holdings, Inc. | 6.51B | -0.30% | 877,041 | 1.56B |
| 140 | HIMS | Hims & Hers Health, Inc. | 6.47B | -4.87% | 9,827,824 | 2.58B |
| 141 | IOVA | Iovance Biotherapeutics, Inc. | 6.38B | -0.35% | 7,760,272 | 324.97M |
| 142 | BLCO | Bausch + Lomb Corporation | 6.24B | 0.23% | 412,125 | 5.32B |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.15B | -1.79% | 536,980 | 239.92M |
| 144 | LGND | Ligand Pharmaceuticals Incorporated | 6.05B | -1.39% | 366,502 | 290.54M |
| 145 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.99B | -5.03% | 576,507 | 840.85M |
| 146 | DOCS | Doximity, Inc. | 5.95B | -0.86% | 1,592,331 | 655.57M |
| 147 | BLTE | Belite Bio, Inc | 5.93B | -1.96% | 49,540 | - |
| 148 | GRAL | GRAIL, Inc. | 5.92B | 4.32% | 574,950 | 165.26M |
| 149 | IMVT | Immunovant, Inc. | 5.87B | -2.37% | 641,348 | - |
| 150 | MANE | Veradermics, Incorporated | 5.80B | 0.21% | 426,410 | - |
| 151 | TFX | Teleflex Incorporated | 5.77B | -0.21% | 505,101 | 2.25B |
| 152 | MMSI | Merit Medical Systems, Inc. | 5.57B | -0.68% | 750,685 | 1.58B |
| 153 | RDNT | RadNet, Inc. | 5.54B | 0.11% | 403,814 | 2.27B |
| 154 | WAY | Waystar Holding Corp. | 5.53B | -0.45% | 1,559,384 | 1.21B |
| 155 | KOD | Kodiak Sciences Inc. | 5.50B | 2.16% | 526,917 | - |
| 156 | CGON | CG Oncology, Inc. | 5.47B | -1.33% | 1,065,124 | 6.23M |
| 157 | COGT | Cogent Biosciences, Inc. | 5.42B | -0.32% | 1,774,730 | - |
| 158 | HAE | Haemonetics Corporation | 5.39B | 2.02% | 777,377 | 1.35B |
| 159 | STVN | Stevanato Group S.p.A. | 5.32B | -0.05% | 403,467 | 1.40B |
| 160 | ORKA | Oruka Therapeutics, Inc. | 5.31B | -1.23% | 513,993 | - |
| 161 | MIRM | Mirum Pharmaceuticals, Inc. | 5.22B | -3.26% | 788,213 | 618.07M |
| 162 | SHC | Sotera Health Company | 5.17B | -0.17% | 1,691,609 | 1.22B |
| 163 | MMED | MiniMed Group, Inc. | 5.16B | 0.27% | 4,801,643 | 3.22B |
| 164 | BLLN | BillionToOne, Inc. | 5.09B | 1.98% | 476,667 | 397.41M |
| 165 | PTCT | PTC Therapeutics, Inc. | 5.06B | -3.89% | 674,315 | 1.01B |
| 166 | SRRK | Scholar Rock Holding Corporation | 5.05B | -1.12% | 1,207,200 | - |
| 167 | ERAS | Erasca, Inc. | 5.03B | 2.49% | 3,499,872 | - |
| 168 | CON | Concentra Group Holdings Parent, Inc. | 5.01B | -1.80% | 1,279,949 | 2.29B |
| 169 | LFST | LifeStance Health Group, Inc. | 4.94B | 2.95% | 2,982,879 | 1.58B |
| 170 | HTFL | HeartFlow, Inc. | 4.93B | 2.31% | 1,556,315 | 212.07M |
| 171 | DFTX | Definium Therapeutics, Inc. | 4.79B | -0.92% | 1,754,048 | - |
| 172 | CRSP | CRISPR Therapeutics AG | 4.78B | -1.20% | 2,120,165 | 13.39M |
| 173 | TVTX | Travere Therapeutics, Inc. | 4.72B | -4.48% | 2,314,585 | 591.33M |
| 174 | OPCH | Option Care Health, Inc. | 4.68B | -0.22% | 2,652,076 | 5.69B |
| 175 | LIVN | LivaNova PLC | 4.46B | -0.46% | 572,060 | 1.47B |
| 176 | ITGR | Integer Holdings Corporation | 4.30B | -0.02% | 603,129 | 1.84B |
| 177 | DNTH | Dianthus Therapeutics, Inc. | 4.29B | -2.23% | 379,234 | 1.90M |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 4.27B | -1.70% | 911,096 | - |
| 179 | ICUI | ICU Medical, Inc. | 4.17B | -1.02% | 272,242 | 2.16B |
| 180 | ADPT | Adaptive Biotechnologies Corporation | 4.07B | 4.51% | 1,876,578 | 308.08M |
| 181 | INDV | Indivior Pharmaceuticals, Inc. | 4.07B | -2.43% | 1,484,012 | 1.33B |
| 182 | IRTC | iRhythm Holdings, Inc. | 4.00B | 1.36% | 456,510 | 825.34M |
| 183 | RLAY | Relay Therapeutics, Inc. | 3.98B | -0.87% | 1,898,922 | 10.35M |
| 184 | TNGX | Tango Therapeutics, Inc. | 3.94B | -16.43% | 15,852,978 | 53.81M |
| 185 | ARQT | Arcutis Biotherapeutics, Inc. | 3.92B | -3.11% | 1,842,368 | 463.98M |
| 186 | VCYT | Veracyte, Inc. | 3.85B | 4.11% | 905,960 | 561.90M |
| 187 | ABCL | AbCellera Biologics Inc. | 3.83B | 3.96% | 2,967,183 | 66.17M |
| 188 | LQDA | Liquidia Corporation | 3.82B | 7.46% | 3,805,641 | 450.91M |
| 189 | RGC | Regencell Bioscience Holdings Limited | 3.80B | -21.81% | 476,525 | - |
| 190 | NVST | Envista Holdings Corporation | 3.79B | -1.54% | 2,768,347 | 2.86B |
| 191 | PLSE | Pulse Biosciences, Inc. | 3.78B | 0.65% | 452,835 | 1.19M |
| 192 | LEGN | Legend Biotech Corporation | 3.73B | 1.96% | 979,530 | 1.27B |
| 193 | NHC | National HealthCare Corporation | 3.70B | -2.90% | 192,910 | 1.56B |
| 194 | OGN | Organon & Co. | 3.61B | - | 1,054,002 | 6.13B |
| 195 | CDNA | CareDx, Inc. | 3.58B | 0.07% | 732,079 | 458.09M |
| 196 | XENE | Xenon Pharmaceuticals Inc. | 3.42B | -3.18% | 636,797 | 7.50M |
| 197 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.41B | -4.80% | 1,140,999 | -665.00K |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.40B | -2.86% | 1,054,429 | 1.14B |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.35B | -3.90% | 1,128,963 | 234.13M |
| 200 | IRON | Disc Medicine, Inc. | 3.31B | -0.69% | 1,963,017 | - |
| 201 | WRBY | Warby Parker Inc. | 3.20B | 0.93% | 1,912,760 | 911.61M |
| 202 | CELC | Celcuity Inc. | 3.19B | -0.49% | 1,316,079 | - |
| 203 | TLX | Telix Pharmaceuticals Limited | 3.15B | -4.09% | 413,435 | 890.79M |
| 204 | ELVN | Enliven Therapeutics, Inc. | 3.04B | -0.98% | 2,298,502 | - |
| 205 | PBLS | Parabilis Medicines, Inc. | 3.02B | -9.21% | 1,820,369 | 148.00K |
| 206 | ATRC | AtriCure, Inc. | 3.00B | -0.56% | 489,073 | 569.62M |
| 207 | TARS | Tarsus Pharmaceuticals, Inc. | 2.99B | -5.38% | 556,619 | 606.33M |
| 208 | DNLI | Denali Therapeutics Inc. | 2.94B | -1.34% | 1,005,556 | 3.60M |
| 209 | ACHC | Acadia Healthcare Company, Inc. | 2.93B | -1.16% | 1,449,464 | 3.37B |
| 210 | AVAH | Aveanna Healthcare Holdings Inc. | 2.92B | 0.45% | 1,820,377 | 2.60B |
| 211 | DYN | Dyne Therapeutics, Inc. | 2.92B | -0.95% | 2,134,278 | - |
| 212 | PRVA | Privia Health Group, Inc. | 2.86B | -2.10% | 669,353 | 2.36B |
| 213 | VKTX | Viking Therapeutics, Inc. | 2.85B | -5.54% | 4,675,326 | - |
| 214 | NRIX | Nurix Therapeutics, Inc. | 2.77B | -0.67% | 1,910,198 | 701.94M |
| 215 | ZLAB | Zai Lab Limited | 2.70B | 9.03% | 3,691,465 | 449.61M |
| 216 | NEOG | Neogen Corporation | 2.66B | 1.75% | 2,652,343 | 884.00M |
| 217 | VRDN | Viridian Therapeutics, Inc. | 2.53B | -1.97% | 1,179,021 | 71.13M |
| 218 | HCM | HUTCHMED (China) Limited | 2.51B | 0.56% | 23,385 | 549.12M |
| 219 | GRDN | Guardian Pharmacy Services, Inc. | 2.50B | -0.38% | 242,068 | 1.46B |
| 220 | TMDX | TransMedics Group, Inc. | 2.45B | -1.83% | 789,563 | 668.47M |
| 221 | CLOV | Clover Health Investments, Corp. | 2.44B | -2.75% | 3,318,872 | 2.48B |
| 222 | BHC | Bausch Health Companies Inc. | 2.41B | -0.77% | 2,427,281 | 10.85B |
| 223 | BKD | Brookdale Senior Living Inc. | 2.41B | -1.08% | 3,665,550 | 2.93B |
| 224 | BEAM | Beam Therapeutics Inc. | 2.40B | -2.08% | 1,582,219 | 156.04M |
| 225 | ADMA | ADMA Biologics, Inc. | 2.39B | -2.47% | 1,735,190 | 512.28M |
| 226 | SUPN | Supernus Pharmaceuticals, Inc. | 2.37B | -3.26% | 1,159,336 | 830.44M |
| 227 | RCUS | Arcus Biosciences, Inc. | 2.36B | -4.24% | 5,925,216 | 117.00M |
| 228 | NAMS | NewAmsterdam Pharma Company N.V. | 2.36B | -8.67% | 2,311,179 | 7.12M |
| 229 | MBX | MBX Biosciences, Inc. | 2.34B | -3.88% | 581,555 | - |
| 230 | SLS | SELLAS Life Sciences Group, Inc. | 2.33B | 1.67% | 3,279,155 | - |
| 231 | MD | Pediatrix Medical Group, Inc. | 2.32B | -0.88% | 574,871 | 1.95B |
| 232 | CLDX | Celldex Therapeutics, Inc. | 2.30B | 0.97% | 879,732 | 158.00K |
| 233 | UFPT | UFP Technologies, Inc. | 2.29B | -0.52% | 112,181 | 631.64M |
| 234 | PBH | Prestige Consumer Healthcare Inc. | 2.26B | -3.36% | 530,104 | 1.10B |
| 235 | FTRE | Fortrea Holdings Inc. | 2.25B | -1.21% | 1,000,269 | 2.68B |
| 236 | AUPH | Aurinia Pharmaceuticals Inc. | 2.24B | -2.71% | 641,219 | 311.51M |
| 237 | AXGN | Axogen, Inc. | 2.23B | 3.76% | 2,149,687 | 251.17M |
| 238 | ADUS | Addus HomeCare Corporation | 2.23B | -0.70% | 221,385 | 1.48B |
| 239 | PGNY | Progyny, Inc. | 2.22B | -0.52% | 565,856 | 1.31B |
| 240 | PGEN | Precigen, Inc. | 2.22B | -3.13% | 4,347,275 | 85.72M |
| 241 | PRGO | Perrigo Company plc | 2.21B | -2.50% | 1,555,735 | 4.14B |
| 242 | RXRX | Recursion Pharmaceuticals, Inc. | 2.21B | 3.35% | 19,075,336 | 54.86M |
| 243 | AGIO | Agios Pharmaceuticals, Inc. | 2.21B | -0.51% | 913,218 | 98.34M |
| 244 | PHVS | Pharvaris N.V. | 2.21B | 2.38% | 621,705 | - |
| 245 | VCEL | Vericel Corporation | 2.18B | -1.02% | 494,729 | 306.30M |
| 246 | NEO | NeoGenomics, Inc. | 2.13B | 1.22% | 1,431,467 | 766.30M |
| 247 | ALMR | Alamar Biosciences, Inc. | 2.13B | 3.26% | 715,949 | 100.42M |
| 248 | HRMY | Harmony Biosciences Holdings, Inc. | 2.10B | 0.28% | 2,313,563 | 959.90M |
| 249 | BHVN | Biohaven Ltd. | 2.10B | -5.51% | 4,693,558 | - |
| 250 | INSP | Inspire Medical Systems, Inc. | 2.06B | -2.13% | 592,144 | 898.74M |
| 251 | IMNM | Immunome, Inc. | 2.04B | -1.48% | 1,378,900 | 4.02M |
| 252 | SGRY | Surgery Partners, Inc. | 2.04B | -0.94% | 3,332,489 | 3.37B |
| 253 | LKFT | Lakefront Biotherapeutics NV | 2.02B | 0.80% | 294,935 | 1.13B |
| 254 | VERA | Vera Therapeutics, Inc. | 2.02B | -3.65% | 1,981,805 | - |
| 255 | TRLV | Trulieve Cannabis Corp. | 2.01B | -4.58% | 1,398,613 | 1.14B |
| 256 | ZYME | Zymeworks Inc. | 2.00B | -0.77% | 1,123,543 | 37.13M |
| 257 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | -0.28% | 176,926 | 6.13M |
| 258 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.95B | -1.67% | 2,710,631 | 940.61M |
| 259 | LMAT | LeMaitre Vascular, Inc. | 1.93B | -1.03% | 184,541 | 262.43M |
| 260 | ASTH | Astrana Health, Inc. | 1.92B | -1.47% | 191,968 | 3.84B |
| 261 | ESTA | Establishment Labs Holdings Inc. | 1.90B | 0.44% | 346,222 | 245.82M |
| 262 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.90B | 3.54% | 1,447,715 | 208.78M |
| 263 | SEPN | Septerna, Inc. | 1.89B | -1.15% | 200,302 | 98.88M |
| 264 | XRAY | DENTSPLY SIRONA Inc. | 1.88B | -0.74% | 3,702,693 | 3.64B |
| 265 | SRPT | Sarepta Therapeutics, Inc. | 1.87B | -2.48% | 1,285,414 | 1.97B |
| 266 | XNCR | Xencor, Inc. | 1.87B | -2.55% | 1,458,063 | 104.97M |
| 267 | XERS | Xeris Biopharma Holdings, Inc. | 1.86B | -6.08% | 2,372,224 | 335.41M |
| 268 | AMN | AMN Healthcare Services, Inc. | 1.86B | 2.54% | 920,597 | 3.43B |
| 269 | MLYS | Mineralys Therapeutics, Inc. | 1.82B | -4.29% | 1,089,646 | - |
| 270 | PVLA | Palvella Therapeutics, Inc. | 1.80B | -1.02% | 164,223 | - |
| 271 | BFLY | Butterfly Network, Inc. | 1.80B | -0.73% | 4,199,629 | 112.14M |
| 272 | TRVI | Trevi Therapeutics, Inc. | 1.80B | -2.55% | 1,376,952 | - |
| 273 | VIR | Vir Biotechnology, Inc. | 1.79B | 1.34% | 1,693,540 | 303.23M |
| 274 | SDGR | Schrödinger, Inc. | 1.78B | 5.31% | 1,156,818 | 259.04M |
| 275 | ZBIO | Zenas BioPharma, Inc. | 1.75B | -4.82% | 377,549 | 1.00M |
| 276 | BRVE | Braveheart Bio, Inc. | 1.75B | -0.19% | 118,835 | - |
| 277 | HCSG | Healthcare Services Group, Inc. | 1.74B | 2.06% | 1,200,112 | 1.88B |
| 278 | ARDT | Ardent Health, Inc. | 1.73B | -0.73% | 358,698 | 6.41B |
| 279 | MAZE | Maze Therapeutics, Inc. | 1.72B | -2.94% | 512,935 | 20.00M |
| 280 | OMCL | Omnicell, Inc. | 1.72B | 1.75% | 754,717 | 1.25B |
| 281 | ATEC | Alphatec Holdings, Inc. | 1.72B | -2.20% | 3,146,920 | 815.05M |
| 282 | KMTS | Kestra Medical Technologies, Ltd. | 1.71B | 1.55% | 357,212 | 106.73M |
| 283 | NVCR | NovoCure Limited | 1.71B | -2.78% | 1,125,125 | 699.19M |
| 284 | PSNL | Personalis, Inc. | 1.69B | 0.19% | 1,115,836 | 69.67M |
| 285 | URGN | UroGen Pharma Ltd. | 1.69B | -1.88% | 738,096 | 188.73M |
| 286 | WGS | GeneDx Holdings Corp. | 1.67B | -16.37% | 2,563,527 | 454.43M |
| 287 | ALHC | Alignment Healthcare, Inc. | 1.67B | -4.39% | 5,067,362 | 4.58B |
| 288 | KLRA | Kailera Therapeutics, Inc. | 1.67B | -3.17% | 1,560,571 | - |
| 289 | ALVO | Alvotech | 1.63B | -4.38% | 661,873 | 494.61M |
| 290 | MESO | Mesoblast Limited | 1.62B | -2.15% | 102,634 | 120.25M |
| 291 | STOK | Stoke Therapeutics, Inc. | 1.62B | -2.57% | 2,156,224 | 27.59M |
| 292 | COAG | Hemab Therapeutics Holdings, Inc. | 1.61B | -1.21% | 271,177 | - |
| 293 | NUVB | Nuvation Bio Inc. | 1.60B | -2.77% | 3,190,760 | 169.90M |
| 294 | SNDA | Sonida Senior Living, Inc. | 1.60B | -0.15% | 359,475 | 481.07M |
| 295 | NVAX | Novavax, Inc. | 1.60B | -2.90% | 4,418,716 | 413.80M |
| 296 | AZTA | Azenta, Inc. | 1.60B | 1.36% | 470,500 | 613.81M |
| 297 | IMCR | Immunocore Holdings plc | 1.60B | -3.55% | 177,888 | 430.78M |
| 298 | GENB | Generate Biomedicines, Inc. | 1.59B | -2.97% | 308,177 | 26.48M |
| 299 | CERT | Certara, Inc. | 1.58B | 2.38% | 2,058,546 | 421.75M |
| 300 | ABSI | Absci Corporation | 1.58B | -2.03% | 1,829,975 | 1.56M |
| 301 | PAHC | Phibro Animal Health Corporation | 1.58B | -2.54% | 102,754 | 1.52B |
| 302 | TRAX | First Tracks Biotherapeutics, Inc. | 1.57B | 2.11% | 849,495 | - |
| 303 | NTLA | Intellia Therapeutics, Inc. | 1.57B | 0.45% | 3,566,493 | 59.51M |
| 304 | LYCA | Lycia Therapeutics, Inc. | 1.56B | 66.67% | 2,286,481 | 4.44M |
| 305 | ANIP | ANI Pharmaceuticals, Inc. | 1.56B | -1.55% | 315,336 | 978.38M |
| 306 | QURE | uniQure N.V. | 1.56B | -2.94% | 884,418 | 18.67M |
| 307 | CMPS | COMPASS Pathways plc | 1.55B | -3.87% | 1,158,767 | - |
| 308 | RARE | Ultragenyx Pharmaceutical Inc. | 1.54B | -1.88% | 1,789,595 | 717.00M |
| 309 | GPCR | Structure Therapeutics Inc. | 1.51B | -3.37% | 798,054 | - |
| 310 | AGL | agilon health, inc. | 1.51B | -0.64% | 189,600 | 5.92B |
| 311 | INVA | Innoviva, Inc. | 1.49B | -1.90% | 978,550 | 440.00M |
| 312 | CNMD | CONMED Corporation | 1.48B | -0.38% | 343,261 | 1.37B |
| 313 | NBTX | Nanobiotix S.A. | 1.47B | 0.58% | 69,406 | 13.15M |
| 314 | PNTG | The Pennant Group, Inc. | 1.46B | -0.83% | 233,319 | 1.10B |
| 315 | ANAB | AnaptysBio, Inc. | 1.46B | 1.31% | 456,362 | 106.09M |
| 316 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.22% | 574,316 | 746.16M |
| 317 | NUTX | Nutex Health Inc. | 1.44B | 1.70% | 128,898 | 846.72M |
| 318 | ETON | Eton Pharmaceuticals, Inc. | 1.43B | -0.04% | 314,767 | 105.60M |
| 319 | OCUL | Ocular Therapeutix, Inc. | 1.43B | -1.66% | 1,855,954 | 52.06M |
| 320 | KRSA | Korsana Biosciences, Inc. | 1.43B | -6.34% | 402,007 | - |
| 321 | AAPG | Ascentage Pharma Group International | 1.42B | 3.49% | 9,367 | 94.61M |
| 322 | TYRA | Tyra Biosciences, Inc. | 1.41B | -2.01% | 520,380 | - |
| 323 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -3.83% | 176,216 | 1.30M |
| 324 | FRNM | Freenome, Inc. | 1.37B | -2.52% | 612,770 | 35.41M |
| 325 | ORIC | ORIC Pharmaceuticals, Inc. | 1.37B | -3.37% | 1,388,794 | - |
| 326 | USPH | U.S. Physical Therapy, Inc. | 1.32B | -0.23% | 102,910 | 804.27M |
| 327 | INNV | InnovAge Holding Corp. | 1.30B | 0.32% | 460,862 | 989.71M |
| 328 | DMRA | Damora Therapeutics, Inc. | 1.30B | -2.86% | 359,783 | - |
| 329 | TSHA | Taysha Gene Therapies, Inc. | 1.29B | -1.12% | 2,592,940 | 5.49M |
| 330 | NKTR | Nektar Therapeutics | 1.27B | -3.70% | 469,613 | 54.59M |
| 331 | BVS | Bioventus Inc. | 1.26B | -0.53% | 383,542 | 581.85M |
| 332 | LBRX | LB Pharmaceuticals Inc | 1.25B | -1.75% | 188,567 | - |
| 333 | RAPP | Rapport Therapeutics, Inc. | 1.24B | -2.26% | 1,185,417 | 20.00M |
| 334 | GHRS | GH Research PLC | 1.24B | -2.32% | 699,429 | - |
| 335 | CRON | Cronos Group Inc. | 1.24B | -2.76% | 816,688 | 179.09M |
| 336 | VSTM | Verastem, Inc. | 1.22B | -0.20% | 3,761,904 | 87.53M |
| 337 | OPK | OPKO Health, Inc. | 1.22B | - | 1,802,902 | 587.90M |
| 338 | ENOV | Enovis Corporation | 1.22B | -2.36% | 954,300 | 2.30B |
| 339 | DRTS | Alpha Tau Medical Ltd. | 1.22B | 2.02% | 324,805 | - |
| 340 | TNDM | Tandem Diabetes Care, Inc. | 1.21B | 1.63% | 1,820,046 | 1.04B |
| 341 | GDRX | GoodRx Holdings, Inc. | 1.21B | -2.21% | 1,137,879 | 785.23M |
| 342 | OMER | Omeros Corporation | 1.20B | -1.72% | 699,351 | 38.42M |
| 343 | KARD | Kardigan, Inc. | 1.20B | 0.47% | 679,813 | - |
| 344 | SNDX | Syndax Pharmaceuticals, Inc. | 1.20B | -1.25% | 4,246,500 | 252.25M |
| 345 | SLN | Silence Therapeutics plc | 1.18B | 0.05% | 2,123,259 | 615.00K |
| 346 | OMDA | Omada Health, Inc. | 1.16B | -0.16% | 678,126 | 309.76M |
| 347 | AVLN | Avalyn Pharma Inc. | 1.15B | -4.44% | 318,175 | - |
| 348 | TDOC | Teladoc Health, Inc. | 1.15B | 0.32% | 2,476,925 | 2.49B |
| 349 | PRCT | PROCEPT BioRobotics Corporation | 1.14B | -0.35% | 773,745 | 337.34M |
| 350 | AORT | Artivion, Inc. | 1.14B | -2.80% | 415,346 | 471.47M |
| 351 | STAA | STAAR Surgical Company | 1.13B | 0.53% | 345,181 | 339.59M |
| 352 | BCAX | Bicara Therapeutics Inc. | 1.13B | -3.07% | 716,052 | - |
| 353 | LMRI | Lumexa Imaging Holdings, Inc. | 1.12B | 7.07% | 650,393 | 1.04B |
| 354 | AHG | Akso Health Group | 1.11B | 6.56% | 1,773 | 13.83M |
| 355 | SPTX | Seaport Therapeutics, Inc. | 1.10B | -0.72% | 164,564 | - |
| 356 | IRMD | IRADIMED CORPORATION | 1.10B | -2.08% | 106,758 | 86.34M |
| 357 | VOR | Vor Biopharma Inc. | 1.08B | -3.59% | 720,921 | - |
| 358 | REPL | Replimune Group, Inc. | 1.08B | -4.42% | 1,904,799 | - |
| 359 | HSTM | HealthStream, Inc. | 1.08B | 1.65% | 205,959 | 321.12M |
| 360 | SVRA | Savara Inc. | 1.07B | -7.05% | 2,828,602 | - |
| 361 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.07B | -3.46% | 470,957 | 730.02M |
| 362 | HROW | Harrow, Inc. | 1.07B | 1.03% | 854,705 | 275.59M |
| 363 | CBLL | CeriBell, Inc. | 1.04B | -0.99% | 491,913 | 101.96M |
| 364 | AVBP | ArriVent BioPharma, Inc. | 1.04B | 9.38% | 3,217,608 | - |
| 365 | CTY | City Therapeutics, Inc. | 1.03B | - | 343,835 | 14.34M |
| 366 | MNKD | MannKind Corporation | 1.03B | -0.31% | 3,089,445 | 393.63M |
| 367 | JANX | Janux Therapeutics, Inc. | 1.02B | -2.34% | 378,883 | 24.00M |
| 368 | CSTL | Castle Biosciences, Inc. | 1.01B | -0.33% | 203,016 | 357.28M |
| 369 | BBNX | Beta Bionics, Inc. | 1.01B | -0.93% | 809,225 | 119.01M |
| 370 | MLTX | MoonLake Immunotherapeutics | 1.01B | -3.97% | 1,934,902 | - |
| 371 | IMTX | Immatics N.V. | 999.20M | -3.05% | 695,976 | 47.65M |
| 372 | LTGO | Latigo Biotherapeutics, Inc. | 995.82M | -9.35% | 146,039 | - |
| 373 | SIBN | SI-BONE, Inc. | 962.70M | -0.37% | 469,087 | 213.60M |
| 374 | SGP | SpyGlass Pharma, Inc. | 952.60M | 0.92% | 70,596 | - |
| 375 | QDEL | QuidelOrtho Corporation | 941.54M | 1.85% | 1,407,393 | 2.67B |
| 376 | ODTX | Odyssey Therapeutics, Inc. | 939.20M | 2.73% | 209,329 | 99.00K |
| 377 | JBIO | Jade Biosciences, Inc. | 927.89M | -2.15% | 634,374 | - |
| 378 | IART | Integra LifeSciences Holdings Corporation | 926.27M | -3.41% | 1,212,688 | 1.66B |
| 379 | GLUE | Monte Rosa Therapeutics, Inc. | 924.80M | -2.43% | 817,746 | 28.73M |
| 380 | CGEM | Cullinan Therapeutics, Inc. | 924.78M | -3.69% | 485,201 | - |
| 381 | RIGL | Rigel Pharmaceuticals, Inc. | 899.06M | -1.49% | 119,259 | 276.79M |
| 382 | CRVS | Corvus Pharmaceuticals, Inc. | 885.79M | -1.13% | 933,758 | - |
| 383 | MGTX | MeiraGTx Holdings plc | 884.56M | -5.73% | 595,703 | 397.50M |
| 384 | ALMS | Alumis Inc. | 877.57M | -0.59% | 1,219,367 | 7.40M |
| 385 | AKTS | Aktis Oncology, Inc. | 874.89M | -6.15% | 236,331 | 10.06M |
| 386 | OBX | Obsidian Therapeutics, Inc. | 863.58M | 0.29% | 279,756 | - |
| 387 | ANRO | Alto Neuroscience, Inc. | 862.15M | -1.04% | 379,247 | - |
| 388 | KURA | Kura Oncology, Inc. | 854.91M | -2.54% | 1,564,976 | 77.23M |
| 389 | GMRS | GMR Solutions Inc. | 833.95M | -0.37% | 356,856 | 5.88B |
| 390 | ABUS | Arbutus Biopharma Corporation | 830.96M | -0.24% | 2,017,279 | 181.72M |
| 391 | IVA | Inventiva S.A. | 809.65M | 3.06% | 4,712,826 | 2.81M |
| 392 | AHCO | AdaptHealth Corp. | 803.12M | -2.43% | 1,627,547 | 3.36B |
| 393 | INMD | InMode Ltd. | 803.01M | -0.57% | 420,688 | 374.63M |
| 394 | PHAR | Pharming Group N.V. | 802.10M | 4.97% | 25,784 | 366.48M |
| 395 | APMD | Apnimed, Inc. | 790.57M | 2.48% | 269,394 | 115.12M |
| 396 | PHR | Phreesia, Inc. | 788.30M | -0.16% | 696,514 | 507.79M |
| 397 | VREX | Varex Imaging Corporation | 776.36M | 0.05% | 368,067 | 865.00M |
| 398 | ARDX | Ardelyx, Inc. | 767.50M | -3.75% | 4,781,378 | 450.89M |
| 399 | COLL | Collegium Pharmaceutical, Inc. | 747.48M | -2.30% | 662,372 | 808.21M |
| 400 | HELP | Helus Pharma Inc. | 744.48M | -2.95% | 1,894,727 | - |
| 401 | CTKB | Cytek Biosciences, Inc. | 726.61M | 2.95% | 704,855 | 206.71M |
| 402 | GERN | Geron Corporation | 719.57M | -0.88% | 11,233,109 | 204.56M |
| 403 | ANNX | Annexon, Inc. | 710.92M | -1.57% | 2,509,098 | - |
| 404 | SANA | Sana Biotechnology, Inc. | 697.51M | -1.69% | 1,708,111 | - |
| 405 | STLN | Starling Oncology, Inc. | 683.86M | -2.89% | 1,055,649 | 587.24M |
| 406 | ANL | Adlai Nortye Group Ltd. | 681.33M | - | 78,873 | 18.06M |
| 407 | SGMT | Sagimet Biosciences Inc. | 679.30M | -3.72% | 694,945 | - |
| 408 | OABI | OmniAb, Inc. | 677.52M | -2.51% | 1,283,194 | 38.46M |
| 409 | IAM | Iambic Therapeutics, Inc. | 675.94M | -2.79% | 610,324 | 18.25M |
| 410 | IMMX | Immix Biopharma, Inc. | 675.66M | -2.40% | 1,203,298 | - |
| 411 | DNA | Ginkgo Bioworks Holdings, Inc. | 672.73M | 2.88% | 1,156,002 | 132.42M |
| 412 | ACHV | Achieve Life Sciences, Inc. | 667.84M | -0.15% | 582,434 | - |
| 413 | PACB | Pacific Biosciences of California, Inc. | 655.85M | 2.43% | 5,717,209 | 159.27M |
| 414 | SLBT | SL Science Holding Limited | 655.81M | -12.21% | 31,118 | 3.27M |
| 415 | AURA | Aura Biosciences, Inc. | 653.34M | -2.48% | 712,967 | - |
| 416 | NVCT | Nuvectis Pharma, Inc. | 653.26M | -4.02% | 107,946 | - |
| 417 | PRME | Prime Medicine, Inc. | 652.91M | -1.61% | 4,562,904 | 4.07M |
| 418 | DSGN | Design Therapeutics, Inc. | 640.84M | -2.38% | 210,365 | - |
| 419 | KIDS | OrthoPediatrics Corp. | 639.69M | -0.85% | 174,628 | 252.72M |
| 420 | SLDB | Solid Biosciences Inc. | 634.77M | -4.36% | 769,958 | - |
| 421 | LXRX | Lexicon Pharmaceuticals, Inc. | 631.84M | -4.70% | 2,684,895 | 41.47M |
| 422 | ATTO | Attovia Therapeutics, Inc. | 631.36M | -4.62% | 312,938 | 1.80M |
| 423 | WVE | Wave Life Sciences, Inc. | 626.61M | -5.07% | 2,655,915 | 65.37M |
| 424 | SOPH | SOPHiA GENETICS SA | 625.69M | 4.26% | 455,634 | 86.17M |
| 425 | GYRE | Gyre Therapeutics, Inc. | 620.30M | -0.17% | 151,482 | 109.82M |
| 426 | CADL | Candel Therapeutics, Inc. | 614.44M | -4.18% | 1,159,793 | - |
| 427 | CRMD | CorMedix Inc. | 611.86M | -3.09% | 894,534 | 462.25M |
| 428 | FDMT | 4D Molecular Therapeutics, Inc. | 596.64M | -8.86% | 996,085 | 92.01M |
| 429 | WEAV | Weave Communications, Inc. | 591.99M | 0.14% | 1,241,559 | 257.79M |
| 430 | CLYM | Climb Bio, Inc. | 585.28M | -3.32% | 495,679 | - |
| 431 | ZVRA | Zevra Therapeutics, Inc. | 582.55M | -5.03% | 978,004 | 136.07M |
| 432 | AVR | Anteris Technologies Global Corp. | 572.29M | -2.17% | 881,786 | 2.24M |
| 433 | IRWD | Ironwood Pharmaceuticals, Inc. | 571.73M | -3.08% | 1,261,258 | 389.32M |
| 434 | MDXG | MiMedx Group, Inc. | 569.92M | -0.51% | 1,262,558 | 355.17M |
| 435 | DBVT | DBV Technologies S.A. | 569.30M | 0.72% | 258,344 | 5.04M |
| 436 | PBYI | Puma Biotechnology, Inc. | 568.85M | -2.13% | 559,153 | 231.24M |
| 437 | OLMA | Olema Pharmaceuticals, Inc. | 560.86M | -8.69% | 1,984,562 | - |
| 438 | EVO | Evotec SE | 559.32M | -2.60% | 20,574 | 819.47M |
| 439 | MYGN | Myriad Genetics, Inc. | 556.68M | 1.04% | 2,099,977 | 806.60M |
| 440 | FLGT | Fulgent Genetics, Inc. | 553.06M | 0.55% | 240,057 | 323.93M |
| 441 | ACRS | Aclaris Therapeutics, Inc. | 552.00M | -2.09% | 2,275,731 | 8.22M |
| 442 | STTK | Shattuck Labs, Inc. | 550.99M | -1.96% | 700,487 | 1.00M |
| 443 | CBIO | Crescent Biopharma, Inc. | 548.71M | -2.44% | 390,184 | 11.88M |
| 444 | ETRA | Electra Therapeutics, Inc. | 546.70M | -5.84% | 186,453 | - |
| 445 | EVH | Evolent Health, Inc. | 542.68M | -1.84% | 1,229,186 | 2.10B |
| 446 | TCMD | Tactile Systems Technology, Inc. | 535.50M | 0.42% | 130,815 | 350.31M |
| 447 | ANGO | AngioDynamics, Inc. | 520.00M | 2.87% | 625,482 | 325.38M |
| 448 | DRUG | Bright Minds Biosciences Inc. | 516.67M | -0.40% | 59,192 | - |
| 449 | ENTX | Entera Bio Ltd. | 507.85M | -3.31% | 256,924 | 42.00K |
| 450 | CTMX | CytomX Therapeutics, Inc. | 505.53M | -4.92% | 4,365,898 | 18.30M |
| 451 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 452 | AQST | Aquestive Therapeutics, Inc. | 502.05M | -3.15% | 1,701,846 | 54.09M |
| 453 | DCTH | Delcath Systems, Inc. | 500.36M | -2.24% | 326,441 | 95.42M |
| 454 | SGHT | Sight Sciences, Inc. | 495.24M | -1.10% | 340,863 | 83.38M |
| 455 | VALN | Valneva SE | 493.97M | -1.87% | 6,107 | 163.30M |
| 456 | OCS | Oculis Holding AG | 487.68M | -2.35% | 294,726 | 1.45M |
| 457 | INDP | Indaptus Therapeutics, Inc. | 485.32M | 5.69% | 287,477 | - |
| 458 | NRC | NRC Health | 485.08M | 2.57% | 91,298 | 140.00M |
| 459 | RCEL | AVITA Medical, Inc. | 479.68M | 0.58% | 401,189 | 75.63M |
| 460 | ARVN | Arvinas, Inc. | 477.32M | -5.44% | 643,308 | 316.70M |
| 461 | MASS | 908 Devices Inc. | 474.92M | 1.23% | 232,005 | 60.84M |
| 462 | MNPR | Monopar Therapeutics Inc. | 474.21M | -2.66% | 96,751 | - |
| 463 | NGNE | Neurogene Inc. | 471.27M | -3.01% | 124,509 | 925.00K |
| 464 | DMAC | DiaMedica Therapeutics Inc. | 470.23M | 1.04% | 110,025 | - |
| 465 | CERS | Cerus Corporation | 469.55M | 0.87% | 1,913,778 | 221.55M |
| 466 | BLSM | BlossomHill Therapeutics, Inc. | 465.01M | -7.46% | 80,688 | - |
| 467 | EOLS | Evolus, Inc. | 463.01M | -5.40% | 597,823 | 316.49M |
| 468 | PHAT | Phathom Pharmaceuticals, Inc. | 455.93M | -18.12% | 4,868,160 | 239.66M |
| 469 | EPRX | Eupraxia Pharmaceuticals Inc. | 450.95M | -9.49% | 348,795 | - |
| 470 | SSII | SS Innovations International, Inc. | 450.87M | -5.06% | 41,010 | 52.40M |
| 471 | BWAY | BrainsWay Ltd. | 448.28M | -1.66% | 51,604 | 60.70M |
| 472 | SRZN | Surrozen, Inc. | 445.78M | -1.05% | 1,554,638 | 11.51M |
| 473 | AGMB | AgomAb Therapeutics NV | 445.69M | -2.27% | 51,164 | - |
| 474 | KMDA | Kamada Ltd. | 445.50M | 0.52% | 88,202 | 191.85M |
| 475 | NPCE | NeuroPace, Inc. | 443.13M | -1.75% | 69,067 | 106.99M |
| 476 | MPLT | MapLight Therapeutics, Inc. | 442.94M | -3.39% | 305,637 | - |
| 477 | FTH | Faeth Therapeutics, Inc. | 441.35M | -15.02% | 353,706 | - |
| 478 | RGNX | REGENXBIO Inc. | 440.97M | -6.83% | 1,452,340 | 174.48M |
| 479 | ALLO | Allogene Therapeutics, Inc. | 431.86M | - | 8,387,353 | 4.64M |
| 480 | PROK | ProKidney Corp. | 426.27M | -1.40% | 535,232 | 818.00K |
| 481 | OVID | Ovid Therapeutics Inc. | 421.84M | -8.86% | 2,017,136 | 1.58M |
| 482 | PRTA | Prothena Corporation plc | 420.96M | -0.61% | 386,137 | 54.53M |
| 483 | ALT | Altimmune, Inc. | 412.38M | -2.30% | 2,565,811 | 31.00K |
| 484 | NAUT | Nautilus Biotechnology, Inc. | 412.31M | 24.62% | 13,794,281 | 190.00K |
| 485 | SRTA | Strata Critical Medical, Inc. | 412.26M | -1.06% | 450,356 | 255.98M |
| 486 | TLRY | Tilray Brands, Inc. | 412.12M | -4.10% | 3,775,494 | 963.10M |
| 487 | AUTL | Autolus Therapeutics plc | 409.89M | -2.53% | 1,447,339 | 117.39M |
| 488 | SI | Shoulder Innovations, Inc. | 409.30M | -0.46% | 67,338 | 60.06M |
| 489 | RZLT | Rezolute, Inc. | 404.38M | -0.13% | 1,198,038 | - |
| 490 | ASMB | Assembly Biosciences, Inc. | 403.95M | -2.17% | 201,264 | 74.85M |
| 491 | SPRY | ARS Pharmaceuticals, Inc. | 400.77M | -6.71% | 1,522,065 | 116.93M |
| 492 | OFIX | Orthofix Medical Inc. | 399.59M | -1.80% | 247,597 | 833.19M |
| 493 | CTEV | Claritev Corporation | 398.27M | - | 690,787 | 994.67M |
| 494 | SENS | Senseonics Holdings, Inc. | 397.08M | 1.49% | 477,173 | 48.55M |
| 495 | CARL | Carlsmed, Inc. | 396.71M | -0.55% | 54,827 | 63.30M |
| 496 | TKNO | Alpha Teknova, Inc. | 396.13M | 4.39% | 875,777 | 43.70M |
| 497 | CYH | Community Health Systems, Inc. | 395.74M | 0.34% | 924,329 | 11.98B |
| 498 | EIKN | Eikon Therapeutics, Inc. | 393.24M | -11.89% | 318,323 | - |
| 499 | TECX | Tectonic Therapeutic, Inc. | 392.36M | -4.84% | 144,840 | - |
| 500 | AUNA | Auna S.A. | 381.91M | 2.58% | 271,736 | 1.37B |